1-205059101-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005076.5(CNTN2):​c.505C>T​(p.Leu169Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0032 in 1,614,204 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0022 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 10 hom. )

Consequence

CNTN2
NM_005076.5 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.717

Publications

10 publications found
Variant links:
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial adult myoclonic, 5
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009752125).
BP6
Variant 1-205059101-C-T is Benign according to our data. Variant chr1-205059101-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445932.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00224 (342/152342) while in subpopulation NFE AF = 0.00414 (282/68034). AF 95% confidence interval is 0.00375. There are 2 homozygotes in GnomAd4. There are 155 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN2NM_005076.5 linkc.505C>T p.Leu169Phe missense_variant Exon 6 of 23 ENST00000331830.7 NP_005067.1 Q02246A1ML24A1L3A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN2ENST00000331830.7 linkc.505C>T p.Leu169Phe missense_variant Exon 6 of 23 1 NM_005076.5 ENSP00000330633.4 Q02246

Frequencies

GnomAD3 genomes
AF:
0.00225
AC:
343
AN:
152224
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00416
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00260
AC:
653
AN:
251318
AF XY:
0.00255
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00443
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00330
AC:
4827
AN:
1461862
Hom.:
10
Cov.:
32
AF XY:
0.00333
AC XY:
2421
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33480
American (AMR)
AF:
0.00226
AC:
101
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000536
AC:
14
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00101
AC:
87
AN:
86258
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53412
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.00399
AC:
4439
AN:
1111992
Other (OTH)
AF:
0.00205
AC:
124
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
251
502
754
1005
1256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00224
AC:
342
AN:
152342
Hom.:
2
Cov.:
32
AF XY:
0.00208
AC XY:
155
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000649
AC:
27
AN:
41582
American (AMR)
AF:
0.00118
AC:
18
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4830
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00414
AC:
282
AN:
68034
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00326
Hom.:
1
Bravo
AF:
0.00255
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00267
AC:
324
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00365
EpiControl
AF:
0.00474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CNTN2: BS2 -

Mar 09, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CNTN2-related disorder Benign:1
Jan 09, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy, familial adult myoclonic, 5 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
T;T;.
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.0088
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.88
.;.;D
M_CAP
Benign
0.0037
T
MetaRNN
Benign
0.0098
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.82
L;L;.
PhyloP100
0.72
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.7
.;N;.
REVEL
Benign
0.044
Sift
Benign
0.21
.;T;.
Sift4G
Benign
0.34
.;T;.
Polyphen
0.060
B;B;.
Vest4
0.27
MVP
0.48
MPC
0.52
ClinPred
0.016
T
GERP RS
4.0
PromoterAI
0.011
Neutral
Varity_R
0.36
gMVP
0.67
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142502980; hg19: chr1-205028229; API